ESPE Abstracts (2023) 97 P2-115

ESPE2023 Poster Category 2 GH and IGFs (15 abstracts)

Are there sex differences among patients to whom a growth hormone (GH) test with clonidina stimulus was required during the study of short stature?

Amaya Vela , Maria GarcÍA , Jon Izquierdo , Alberto Ugeso , Gema Grau & Itxaso Rica


Hospital Universitario De Cruces, Barakaldo, Spain


Introduction: GH stimulus test is usually performed in pacientes With short stature and/or growth delayed study if GH deficit is suspected. Several articles concluded that male are more frequently diagnosed and treated of GH deficiency than female

Objectives: To know gender's ratio and the possible anthropometric differences between patients that required a consult for short stature and to whom a stimulus test was performed with clonidine during 3 years.

Patients and Methods: We retrospectivelly reviewed all patients sent to a specialised ofrece between 2015 to 2017 due to short stature and/or growth delayed, in which a clonidine stimulus test was performed between. Patients with chronic diseases, syndromes, and patients diagnosed of oncologic diseases were excluded. Clonidine stimulus test was carried out in the morning. Pacientes came to the hospital fasting hospital during the day, fasting, and the clonidine dose was weight dependant. After the administration of clonidine, GH levels were measured at minute 0, 60, 90, and 120 with a chemiluminescence Immunoassay with Inmulite 2000 (Siemens). For standard deviation conversion, we used local growth graphics. SPSS V25 was usted for statistical analysis

Results: 108 patients (39% girls) were included; mean age was 10.7 years. 65% were Prepubertal patients. Variables: Height-SDS, BMI-SDS and Target-Height (TH)-SDS.

Table 1. Clinical characteristics:
Age 1st consult (years) Clonidine test age (years) Height (SDS) BMI (SDS) TH- Height (SDS)
All 9.2±2.9 10.7±2.6 -2.4±0.61 --0.29±1.1 1.7±1.05
Boys 9.4±3.1 11.22±2.7 -2.3±0.53 -0.41±1.13 1.4±1.05
Girls 8.7±2.7 9.8±2.4 -2,6±0.68 -0.12±1.08 2.1±0.93

More than 75% of the patients had low weight. Only eight patients had obesity or overweight. Of them, seven had not response to the clonidine stimulus. All patients excepto two were below their mid parental height. Even if there was a peak in the answer at every time, the 90% was present in the minutes 60 and 90 (52% in the minute 60 and 33% in the minute 90). During follow-up, 30% were finally diagnosed and treated as GH deficit (30% of the girls and 29% of the boys). No significant differences.

Conclusions: 1. In our series, male did not benefit from the diagnostic and treatment of GH deficiency. 2. In this samples, most of the patients that participated, presented low weight, a factor that may affect in the adequate growth rate.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.